Enhanced by remote monitoring, telemedicine, and wearable devices, this market is booming across North America and Asia Pacific. Blood glucose monitoring dominates, while cardiac devices are rapidly ...

HeartBeam announced that it entered into a strategic collaboration with AccurKardia to enhance cardiac monitoring ...

Key drivers include the rising burden of cardiovascular diseases and demand for long-term monitoring solutions like ...

As per Future Market Insights’ latest industry analysis, the valuation for the global cardiac ambulatory monitoring market was around USD 13.9 Billion in 2022 and is projected to exhibit a CAGR close ...

Rhythm (Nasdaq: IRTC) today announced new results supporting its Zio long-term continuous monitoring (LTCM) ECG patch.

HeartBeam has announced a partnership with AccurKardia, aimed at improving cardiac monitoring solutions’ accessibility.

(MENAFN- GlobeNewsWire - Nasdaq) Key drivers include the rising burden of cardiovascular diseases and demand for long-term monitoring solutions like implantable cardiac monitors. Major companies ...

HeartBeam (NASDAQ: BEAT) , a medical technology firm innovating in personalized cardiac care, has announced a strategic collaboration with AccurKardi ...

Backed by a voter-approved bond, St. Charles County Ambulance District is building its largest station and adding 70+ cardiac ...

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

UCSF is launching a remote patient monitoring program aimed at identifying arrhythmias in expectant mothers and improving ...

If someone is afflicted with heart disease, it's important that their cardiac activity be monitored as frequently and accurately as possible. An experimental new wearable device is designed to ...